Papers by Marco A. Prado · AgingResearch.News

bioRxiv20 Aug
Myelin maturation failure and oligodendrocyte precursor loss underlie default mode network disruption in a humanized APP knock-in model of Alzheimers disease
Preprint: experiments in animalsMechanisms
Paper
AAIC 2025 Abstract28 Dec
Evaluating the Efficacy and Risks of Early Lecanemab Treatment in APOE4 Humanized Alzheimer's Disease Mouse Models
Experiments in animalsInterventions
Paper
AAIC 2025 Abstract26 Dec
Translational cognitive biomarkers for preclinical drug testing in neurodegenerative diseases
Experiments in animalsInterventions
Paper
AAIC 2025 Abstract25 Dec
TRanslational Initiative to DE‐risk NeuroTherapeutics (TRIDENT) – A revolutionary pre‐clinical approach to maximize the predictive validity of pre‐clinical evaluation
Interventions
Paper

AAIC 2025 Abstract24 Dec
Reduced cholinergic tone and hippocampal‐dependent cognitive impairments in APP NL‐F mice
Experiments in animalsMechanisms
Paper
AAIC 2025 Abstract24 Dec
The Multifactorial Impact of ApoE4 on Alzheimer's Pathology and Cognitive Decline
Experiments in animalsMechanisms
Paper
AAIC 2025 Abstract24 Dec
Tau pathology in triple knock‐in mouse model of Alzheimer's Disease expressing APOE3 and APOE4
Experiments in animalsMechanisms
Paper
AAIC 2025 Abstract23 Dec
Apolipoprotein E (ApoE) 4 exacerbates pattern separation deficits and amyloid pathology in a combined humanized knock‐in Apolipoprotein E, Amyloid, and Tau model of Alzheimer's Disease
Experiments in animalsMechanisms
Paper